Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma (Q41017874)

25 September 2017

Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma (English)

1 reference

25 September 2017

6

1 reference

25 September 2017

Jiyoung Ahn

2

0 references

William B Isaacs

7

object named as

William B Isaacs

1 reference

25 September 2017

1

Adam S Kibel

1 reference

25 September 2017

Masis Isikbay

3

1 reference

25 September 2017

Aleksandra Klim

4

1 reference

25 September 2017

William S Wu

5

1 reference

25 September 2017

E Warwick Daw

8

1 reference

25 September 2017

28 December 2015

1 reference

25 September 2017

1 reference

25 September 2017

76

1 reference

25 September 2017

5

1 reference

25 September 2017

479-490

1 reference

25 September 2017

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Active surveillance for early-stage prostate cancer: review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Castration-resistant prostate cancer: AUA guideline amendment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Genetic background is an important determinant of metastatic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A systems biology approach to defining metastatic biomarkers and signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Chromosome 8q24 markers: risk of early-onset and familial prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Sequence variants at 22q13 are associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Genome-wide association study of prostate cancer-specific survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cell cycle checkpoints: preventing an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

CDK4/6 inhibitors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

New directions for drug-resistant breast cancer: the CDK4/6 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

p53 polymorphic variants at codon 72 exert different effects on cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Functional promoter SNPs in cell cycle checkpoint genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Highly parallel SNP genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

TFIIH is negatively regulated by cdk8-containing mediator complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin C/cdk3 promotes Rb-dependent G0 exit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Stress-Induced CDK5 Activation Disrupts Axonal Transport via Lis1/Ndel1/Dynein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The negative role of cyclin G in ATM-dependent p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Structure, expression, and chromosomal localization of human GAK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Regulation of the p53 response and its relationship to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association between MDM2 SNP309 and skin cancer: A meta-analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Association of MDM2 polymorphism with risk and prognosis of leukemia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

Profiling Genetic Variation along the Androgen Biosynthesis and Metabolism Pathways Implicates Several Single Nucleotide Polymorphisms and Their Combinations as Prostate Cancer Risk Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23139

21 January 2018

Identifiers

DOI

10.1002/PROS.23139

1 reference

25 September 2017

1 reference